The global Treatment Planning Systems And Advanced Image Processing market gathered revenue around USD 2.0 Billion in 2020 and market is set to grow USD 4.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.1% during the prediction period 2021 to 2027.
Growth Factors:
The increasing prevalence of cancer and rising product development pertaining to cancer research undertaken by key players are driving the market growth. According to estimates published by GLOBOCAN in 2020, 19.3 million new cancer cases were diagnosed and 10.0million cancer-related mortalities recorded.
As per the WHO, cancer is the leading cause of death globally and claims one in every six lives. According to Novartis, there are more than 200 types of cancers prevalent in the world and each requires a unique diagnosis and line of treatment. The growing cancer burden is expected to boost the demand for advanced oncology therapies with accurate and efficient results, thereby aiding the market growth.
Moreover, the oncology space is witnessing innovations and investments by market leaders to develop novel technologies that possess the potential to alter the treatment regime drastically. Advancements in healthcare infrastructure and the unraveling of opportunities in emerging markets are contributing to growth. Governments around the world are promoting public-private collaboration to accelerate product development.
Recent developments in the field of imaging technology have found wide-scale adoption in treatment planning, treatment simulation, and image guidance in radiotherapy processes. For instance, in January 2021, OncoLens raised USD 7.3 million in a Series A funding round. Additionally, General Atlantic invested around USD 200.0 million for launching OneOncology, a company designed for helping community oncology practices with technical data, innovation, and research. Furthermore, Purdue Pharma L.P is investing in its oncology R&D to diversify scientific research in high unmet medical need areas and thereby establishing a potential portfolio of delivering new cancer therapies to patients over the forthcoming years.
Furthermore, Artificial Intelligence (AI) and Machine Learning (ML) are witnessing increased adoption in oncology software systems to improve diagnosis, treatment plan, simulation, and management. The amalgamation of AI/ML has significantly improved diagnosis and imaging segments of oncology care. One such highlight of these deep learning algorithms was detecting skin cancer based on skin photographs.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Treatment Planning Systems And Advanced Image Processing market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Treatment Planning Systems And Advanced Image Processing market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 4.2 Billion by 2027 |
Growth Rate | CAGR of 8.1% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Component, Technique, Application and Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Accuray Incorporated; Elekta; Koninklijke Philips NV; RaySearch Laboratories; Varian Medical Systems; Brainlab; Prowess, Inc.; DOSIsoft SA; Viewray, Inc.; MIM Software, Inc |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Treatment Planning Systems And Advanced Image Processing market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
In 2020, North America dominated the market and accounted for the largest revenue share of 38.9% owing to rapid advancements in healthcare infrastructure coupled with increased healthcare expenditure. Rising global cancer prevalence is also a market driving factor in treatment planning systems. The rising demand for effective, accurate, and advanced cancer treatment and care practices in North America has boosted the market growth in this region.
The presence of sophisticated healthcare facilities and cancer research institutes and increased disposable income with an existing reimbursement framework is supporting market development and growth. In North America, cancer accounts for the second leading cause of death. As per Globocan estimates of 2020, U.S. recorded a total of 2.4 million new cancer cases and 0.6 million cancer deaths. Cancer mortality in this region has been declining since 1991 which is due to innovations in treatment practices and early cancer detection.
However, in the Asia Pacific, the market is anticipated to witness a CAGR of 8.7% over the forecast period due to the growth of many developing economies such as India and China. Constant healthcare advancements and widespread adoption of healthcare IT solutions in emerging countries are some of the key factors responsible for market growth. Increasing cancer prevalence and rise in healthcare expenditure by both public and private players are supporting market growth. As per Globocan 2020, Asia Pacific recorded 9,503,710 new cancer cases. Organizations are undertaking initiatives to spread awareness and accelerate penetration. For instance, Asia Pacific Signal and Information Processing Association organizes annual seminars and workshops on topics like image processing and healthcare information technology.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Treatment Planning Systems And Advanced Image Processing Market include: Accuray Incorporated; Elekta; Koninklijke Philips NV; RaySearch Laboratories; Varian Medical Systems; Brainlab; Prowess, Inc.; DOSIsoft SA; Viewray, Inc.; MIM Software, Inc.
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Treatment Planning Systems And Advanced Image Processing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Treatment Planning Systems And Advanced Image Processing market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Treatment Planning Systems And Advanced Image Processing markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Treatment Planning Systems And Advanced Image Processing Market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Treatment Planning Systems And Advanced Image Processing Market, By Component
7.1. Treatment Planning Systems And Advanced Image Processing Market, by Component, 2021-2027
7.1.1. Advanced Image Processing Software
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Treatment Planning Software
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Treatment Planning Systems And Advanced Image Processing Market, By Technique
8.1. Treatment Planning Systems And Advanced Image Processing Market, by Technique, 2021-2027
8.1.1. 3D Image Reconstruction
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. In-Room Imaging
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Image Registration using Graphics Processor Unit
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Treatment Planning Systems And Advanced Image Processing Market, By Application
9.1. Treatment Planning Systems And Advanced Image Processing Market, by Application, 2021-2027
9.1.1. Adaptive Radiotherapy
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Online Monitoring
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Tracking
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Dose Accumulation
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Validation of Image Registration
9.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Treatment Planning Systems And Advanced Image Processing Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Component (2016-2027)
10.1.2. Market Revenue and Forecast, by Technique (2016-2027)
10.1.3. Market Revenue and Forecast, by Application (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Component (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Technique (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Component (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Technique (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Component (2016-2027)
10.2.2. Market Revenue and Forecast, by Technique (2016-2027)
10.2.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Component (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Technique (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Component (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Technique (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Component (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Technique (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Component (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Technique (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Component (2016-2027)
10.3.2. Market Revenue and Forecast, by Technique (2016-2027)
10.3.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Component (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Technique (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Component (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Technique (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Component (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Technique (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Component (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Technique (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Component (2016-2027)
10.4.2. Market Revenue and Forecast, by Technique (2016-2027)
10.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Component (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Technique (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Component (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Technique (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Component (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Technique (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Application (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Component (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Technique (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Application (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Component (2016-2027)
10.5.2. Market Revenue and Forecast, by Technique (2016-2027)
10.5.3. Market Revenue and Forecast, by Application (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Component (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Technique (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Application (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Component (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Technique (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Application (2016-2027)
Chapter 11. Company Profiles
11.1. Accuray Incorporated
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Elekta
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Koninklijke PHILIPS N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. RaySearch Laboratories
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Varian Medical Systems
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Brainlab
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Prowess Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. DOSIsoft SA
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. ViewRay Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. MIM Software Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms